U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101431101431Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 DiabetesTerminatedNo Results AvailableType 2 DiabetesDrug: Tadalafilhttps://ClinicalTrials.gov/show/NCT01238224
101432101432Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaActive, not recruitingHas ResultsAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNDrug: Daunorubicin Hydrochloride|Drug: Cytarabine|Drug: Dasatinib|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT01238211
101433101433Aspirin Mouthwash in Treating Patients With Oral LeukoplakiaCompletedNo Results AvailablePrecancerous ConditionDrug: acetylsalicylic acid|Genetic: gene expression analysis|Genetic: protein expression analysis|Other: laboratory biomarker analysis|Other: questionnaire administration|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT01238185
101434101434Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceActive, not recruitingNo Results AvailableProstate CancerOther: dietary education and counseling|Other: prostate cancer foundation booklethttps://ClinicalTrials.gov/show/NCT01238172
101435101435Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell LymphomaCompletedNo Results AvailableExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeRadiation: CCRT+MIDLE chemotherapyhttps://ClinicalTrials.gov/show/NCT01238159
101436101436Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWithdrawnNo Results AvailableExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|SDrug: bendamustine hydrochloride|Drug: obatoclax mesylate|Biological: rituximabhttps://ClinicalTrials.gov/show/NCT01238146
101437101437Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTerminatedNo Results AvailableEstrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-Negative Breast CarcinomaDrug: Carboplatin|Drug: Gamma-Secretase Inhibitor RO4929097|Other: Laboratory Biomarker Analysis|Drug: Paclitaxel|Other: Pharmacological Study|Procedure: Therapeutic Conventional Surgeryhttps://ClinicalTrials.gov/show/NCT01238133
101438101438The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer PatientsRecruitingNo Results AvailableCancer-related Cognitive DifficultiesDrug: Ibuprofen|Behavioral: Home-Based Exercise (EXCAP)|Drug: Placebo (sugar pill)https://ClinicalTrials.gov/show/NCT01238120
101439101439A Clinical Study With MT-102 in Subjects With Cancer CachexiaCompletedNo Results AvailableCancer CachexiaDrug: MT-102https://ClinicalTrials.gov/show/NCT01238107
101440101440Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal CancerRecruitingNo Results AvailableColorectal CancerDrug: Simvastatinhttps://ClinicalTrials.gov/show/NCT01238094
101441101441The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in AdultsCompletedNo Results AvailableCystic Fibrosishttps://ClinicalTrials.gov/show/NCT01238081
101442101442Comparison of the Results of Treatment by Gamma Nail Versus Dynamic Hip Screw for Unstable Intertrochanteric Hip FracturesNot yet recruitingNo Results AvailableIntertrochanteric Fractures of the HipDevice: gamma nail strykerhttps://ClinicalTrials.gov/show/NCT01238068
101443101443Sunitinib + Docetaxel as Second-line Treatment in Gastric CancerCompletedNo Results AvailableAdvanced Gastric CancerDrug: Docetaxel + Sunitinib|Drug: Docetaxel onlyhttps://ClinicalTrials.gov/show/NCT01238055
101444101444Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's EsophagusCompletedNo Results AvailableBarrett's Esophagus|CIS|HGDDrug: HPPHhttps://ClinicalTrials.gov/show/NCT01238042
101445101445Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast CancerTerminatedNo Results AvailableMetastatic Breast Cancer|HER2 Positive|First or Second Line Therapy|Failure or Contraindication of Trastuzumab TherapyDrug: Lapatinib and Capecitabine and Vinorelbinehttps://ClinicalTrials.gov/show/NCT01238029
101446101446Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot StudySuspendedNo Results AvailableHypoglycemiaDevice: experimentalhttps://ClinicalTrials.gov/show/NCT01238016
101447101447Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized PatientsNot yet recruitingNo Results AvailableANCA-related VasculitisOther: Interpretation of blood test resultshttps://ClinicalTrials.gov/show/NCT01238003
101448101448Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic ProceduresCompletedNo Results AvailableLiver Cancerhttps://ClinicalTrials.gov/show/NCT01237990
101449101449Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar LinesCompletedNo Results AvailableSkin AgingDrug: Botulinum Toxin Type A(Meditoxin®)|Drug: Botulinum Toxin Type A(Botox®)https://ClinicalTrials.gov/show/NCT01237977
101450101450Injectable Collagenase For Burns' Associated ContractureNot yet recruitingNo Results AvailableBurn's Associated ContractureDrug: Xiaflex (FDA approved collagenase)https://ClinicalTrials.gov/show/NCT01237964
101451101451High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk MyelomaActive, not recruitingNo Results AvailableMyelomaDrug: Palifermin|Drug: Dexamethasone|Drug: Gemcitabine|Drug: Busulfan|Drug: Melphalan|Procedure: Stem Cell Transplant|Drug: G-CSFhttps://ClinicalTrials.gov/show/NCT01237951
101452101452Effect of a Low Glycemic Index Diet on Breast DensityTerminatedNo Results AvailableBreast CancerBehavioral: Low Glycemic Diethttps://ClinicalTrials.gov/show/NCT01237938
101453101453Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related SymptomsNot yet recruitingNo Results AvailableSunburnDrug: Dexchlorpheniramine 1% gel|Drug: Dexchlorpheniramine 1% creamhttps://ClinicalTrials.gov/show/NCT01237925
101454101454European Exposure StudyCompletedNo Results AvailableSmokinghttps://ClinicalTrials.gov/show/NCT01237912
101455101455Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium ClearanceCompletedNo Results AvailableChronic Kidney DiseaseDrug: LY2623091|Drug: Placebo|Drug: Eplerenonehttps://ClinicalTrials.gov/show/NCT01237899
101456101456Weaning And Variability EvaluationCompletedNo Results AvailableMechanically Ventilated Patients|Extubationhttps://ClinicalTrials.gov/show/NCT01237886
101457101457Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential HypertensionCompletedNo Results AvailableEssential HypertensionDrug: Ali/Amlo 150/2.5 mghttps://ClinicalTrials.gov/show/NCT01237873
101458101458Evaluation of the Safety and Performance of the NESS L300 Plus SystemCompletedNo Results AvailableFoot Drop|Thigh Muscles Weakness (Hamstrings or Quadriceps)|Upper Motor Neuron Injury or DiseaseDevice: NESS L300 Plus Systemhttps://ClinicalTrials.gov/show/NCT01237860
101459101459A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel DiseaseActive, not recruitingNo Results AvailableInflammatory Bowel DiseaseBehavioral: 2 Family-based problem solving phone sessions|Behavioral: 4 Family-based problem solving phone intervention sessions|Behavioral: Wait list comparison grouphttps://ClinicalTrials.gov/show/NCT01237847
101460101460Physiological Responses in Tobacco ChippersCompletedNo Results AvailableSmoking|Stresshttps://ClinicalTrials.gov/show/NCT01237834

* Görseller ve İçerik tekif hakkına sahip olabilir